Dataset: Transcription profiling of primary human hepatocytes - toxicogenomic comparison of TCDD and PCB 126 responsiveness in primary human hepatocytes
(Abstract) Toxicogenomics has great potential for enhancing our understanding of environmental chemical toxicity, hopefully leading to...
(Abstract) Toxicogenomics has great potential for enhancing our understanding of environmental chemical toxicity, hopefully leading to better-informed human health risk assessments. This study employed toxicogenomic technology to reveal species differences in response to two prototypical aryl hydrocarbon receptor (AHR) agonists, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and the polychlorinated biphenyl (PCB) congener PCB 126. Dose responses of primary cultures of rat and human hepatocytes were determined using species-specific microarrays sharing over 4,000 gene orthologs. Forty-seven human and 79 rat genes satisfied dose response criteria for both chemicals and were subjected to further analysis including the calculation of EC50 and the relative potency (REP) of PCB 126 for each gene. Only 5 responsive orthologous genes were shared between the two species, yet the geometric mean of the REPs for all rat and human modeled responsive genes were 0.06 (95% Confidence Interval (CI); 0.03-0.1) and 0.002 (95% CI; 0.001-0.005), respectively, suggesting broad species differences in the initial events that follow AHR activation but precede toxicity. This indicates that there are species differences in both the specific genes that responded and the agonist potency and relative potency for those genes. This observed insensitivity of human cells to PCB 126 is consistent with more traditional measurements of AHR activation (i.e., CYP1A1 enzyme activity) and suggests that the species difference in PCB 126 sensitivity is likely due to certain aspects of AHR function. That a species divergence also exists in this expanded AHR-regulated gene repertoire is a novel finding and should help when extrapolating animal data to humans. Experiment Overall Design: Primary hepatocyte cultures derived from 3 human donors were treated with vehicle (0.5% DMSO), TCDD (-14 to -6.5 log10 M) , or PCB 126 (-12 to -5 log10 M) for 48h. Total RNA was extracted and screened with HG-U133A microarrays for dose response.
- Species:
- human
- Samples:
- 40
- Source:
- E-GEOD-14553
- Updated:
- Dec.12, 2014
- Registered:
- Jun.19, 2014
Sample |
---|
GSE14553GSM364049 |
GSE14553GSM364050 |
GSE14553GSM364051 |
GSE14553GSM364052 |
GSE14553GSM364053 |
GSE14553GSM364054 |
GSE14553GSM364055 |
GSE14553GSM364056 |
GSE14553GSM364057 |
GSE14553GSM364058 |
GSE14553GSM364059 |
GSE14553GSM364060 |
GSE14553GSM364061 |
GSE14553GSM364062 |
GSE14553GSM364063 |
GSE14553GSM364064 |
GSE14553GSM364065 |
GSE14553GSM364066 |
GSE14553GSM364067 |
GSE14553GSM364068 |
GSE14553GSM364069 |
GSE14553GSM364070 |
GSE14553GSM364071 |
GSE14553GSM364072 |
GSE14553GSM364073 |
GSE14553GSM364074 |
GSE14553GSM364075 |
GSE14553GSM364076 |
GSE14553GSM364077 |
GSE14553GSM364078 |
GSE14553GSM364079 |
GSE14553GSM364080 |
GSE14553GSM364081 |
GSE14553GSM364082 |
GSE14553GSM364083 |
GSE14553GSM364084 |
GSE14553GSM364085 |
GSE14553GSM364086 |
GSE14553GSM364087 |
GSE14553GSM364088 |